Tomoko Yamamoto Funazo

4PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 07, 2026
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation.

|Dec 05, 2023
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.

Tatsuya Ogimoto, Hiroaki Ozasa, Takahiro Tsuji

|Jan 05, 2020
YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation.

Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki

|Nov 21, 2019
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab.

Tomoko Yamamoto Funazo, Takashi Nomizo, Hiroaki Ozasa

Pageof 1

Frequent Collaborators

4 joint publications

Takahiro Tsuji

2 joint publications

Hiroaki Ozasa

2 joint publications

Masatoshi Yamazoe

2 joint publications

Kentaro Hashimoto